| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acceptability of a patient decision aid for women aged 70 and older with stage I, estrogen receptor-positive, HER2-negative breast cancer
|
Minami, Christina A.
|
|
|
12 |
5 |
p. 724-730
|
artikel
|
| 2 |
Adoption and effectiveness of de-escalated radiation and endocrine therapy strategies for older women with low-risk breast cancer
|
Reeder-Hayes, Katherine E.
|
|
|
12 |
5 |
p. 731-740
|
artikel
|
| 3 |
Age specific recruitment and retention to a large multicentre observational breast cancer trial in older women: The Age Gap Trial
|
Todd, Annaliza
|
|
|
12 |
5 |
p. 714-723
|
artikel
|
| 4 |
Breast cancer associated pathogenic variants among women 61 years and older with triple negative breast cancer
|
Chávarri-Guerra, Yanin
|
|
|
12 |
5 |
p. 749-751
|
artikel
|
| 5 |
Challenges and opportunities to developing a frailty index using electronic health record data
|
Levit, Laura A.
|
|
|
12 |
5 |
p. 851-854
|
artikel
|
| 6 |
Changes in functional status associated with radiation for prostate cancer in older veterans
|
Ursem, Carling
|
|
|
12 |
5 |
p. 808-812
|
artikel
|
| 7 |
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer
|
Johns, Andrew C.
|
|
|
12 |
5 |
p. 813-819
|
artikel
|
| 8 |
Cognition and depression effects of androgen receptor axis-targeted drugs in men with prostate cancer: A systematic review
|
Batra, Anupam
|
|
|
12 |
5 |
p. 687-695
|
artikel
|
| 9 |
Cost-effectiveness of endocrine therapy versus radiotherapy versus combined endocrine and radiotherapy for older women with early-stage breast cancer
|
Wheeler, Stephanie B.
|
|
|
12 |
5 |
p. 741-748
|
artikel
|
| 10 |
Drug-related problems and potentially inappropriate medications use in Indian geriatric patients receiving chemotherapy in the medical oncology unit of a tertiary care hospital
|
Kanchana, Murugavel
|
|
|
12 |
5 |
p. 840-843
|
artikel
|
| 11 |
Efficacy and safety of second-line axitinib in octogenarians with metastatic renal cell carcinoma
|
Nakai, Yasutomo
|
|
|
12 |
5 |
p. 834-837
|
artikel
|
| 12 |
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) – an International mRCC Database Consortium (IMDC) analysis
|
Araujo, Daniel V.
|
|
|
12 |
5 |
p. 820-826
|
artikel
|
| 13 |
Geriatric phone follow-up including validated cognitive assessment in older patients treated for cancer
|
Lange, Marie
|
|
|
12 |
5 |
p. 838-839
|
artikel
|
| 14 |
IFC (Ed. Board)
|
|
|
|
12 |
5 |
p. IFC
|
artikel
|
| 15 |
Older patients with active cancer have favorable inpatient rehabilitation outcomes
|
Bilek, Aaron Jason
|
|
|
12 |
5 |
p. 799-807
|
artikel
|
| 16 |
Outcomes based on age in patients with metastatic renal cell carcinoma treated with first line targeted therapy or checkpoint immunotherapy: Older patients more prone to toxicity
|
Hermansen, Carina K.
|
|
|
12 |
5 |
p. 827-833
|
artikel
|
| 17 |
Perspectives on Geriatric Hematology Research presented at the 2020 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report
|
Abdallah, Maya
|
|
|
12 |
5 |
p. 860-862
|
artikel
|
| 18 |
Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer
|
Yuan, Yuan
|
|
|
12 |
5 |
p. 752-758
|
artikel
|
| 19 |
Poor patient health is associated with higher caregiver burden for older adults with advanced cancer
|
Semere, Wagahta
|
|
|
12 |
5 |
p. 771-778
|
artikel
|
| 20 |
Predicting disease-related and patient-reported outcomes in older patients with breast cancer - a systematic review
|
van der Plas-Krijgsman, Willeke G
|
|
|
12 |
5 |
p. 696-704
|
artikel
|
| 21 |
Prevalence of functional limitations and their associations with systemic cancer therapy among older adults in nursing homes with advanced non-small cell lung cancer
|
Panagiotou, Orestis A.
|
|
|
12 |
5 |
p. 765-770
|
artikel
|
| 22 |
Role of the vulnerable elders survey-13 screening tool in predicting treatment plan modification for older adults with cancer
|
Almugbel, Fahad A.
|
|
|
12 |
5 |
p. 786-792
|
artikel
|
| 23 |
Social networks of older patients with advanced cancer: Potential contributions of an integrated mixed methods network analysis
|
Yousefi Nooraie, Reza
|
|
|
12 |
5 |
p. 855-859
|
artikel
|
| 24 |
The effect of treatment modifications by an onco-geriatric MDT on one-year mortality, days spent at home and postoperative complications
|
Festen, Suzanne
|
|
|
12 |
5 |
p. 779-785
|
artikel
|
| 25 |
The SIOG COVID-19 working group recommendations on the rollout of COVID-19 vaccines among older adults with cancer
|
Mislang, Anna Rachelle
|
|
|
12 |
5 |
p. 848-850
|
artikel
|
| 26 |
Treatment choices for older women with primary operable breast cancer and cognitive impairment: Results from a prospective, multicentre cohort study
|
Martin, Charlene
|
|
|
12 |
5 |
p. 705-713
|
artikel
|
| 27 |
Validation of the EORTC QLQ-ELD 14 questionnaire to assess the health-related quality of life of older cancer survivors in Chile
|
Lorca, Luz Alejandra
|
|
|
12 |
5 |
p. 844-847
|
artikel
|
| 28 |
Validation of the G8 screening tool in older patients with cancer considered for surgical treatment
|
Bruijnen, Cheryl P.
|
|
|
12 |
5 |
p. 793-798
|
artikel
|
| 29 |
VOTRAGE study: Phase I dose-escalation study of pazopanib in unfit older patients
|
Mourey, Loïc
|
|
|
12 |
5 |
p. 759-764
|
artikel
|
Tijdschrift beschrijving